Birth Control Medication Recalled by FDA Over Quality Concerns
The FDA has announced a nationwide recall of specific lots of Alyacen 7/7/7 birth control tablets. This action follows testing that showed the product did not meet quality standards due to impurities and degradation. As a Class II recall, it indicates a potential for temporary or reversible health issues.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.